137 related articles for article (PubMed ID: 19728760)
1. Activation of HLA-G expression by 5-aza-2 - deoxycytidine in malignant hematopoetic cells isolated from leukemia patients.
Polakova K; Bandzuchova E; Sabty FA; Mistrik M; Demitrovicova L; Russ G
Neoplasma; 2009; 56(6):514-20. PubMed ID: 19728760
[TBL] [Abstract][Full Text] [Related]
2. Demethylating agent 5-aza-2'-deoxycytidine activates HLA-G expression in human leukemia cell lines.
Poláková K; Bandzuchová E; Kuba D; Russ G
Leuk Res; 2009 Apr; 33(4):518-24. PubMed ID: 18823661
[TBL] [Abstract][Full Text] [Related]
3. Analysis of HLA-G expression in malignant hematopoetic cells from leukemia patients.
Poláková K; Krcová M; Kuba D; Russ G
Leuk Res; 2003 Jul; 27(7):643-8. PubMed ID: 12681364
[TBL] [Abstract][Full Text] [Related]
4. Effect of 5-aza-2'-deoxycytidine on immune-associated proteins in exosomes from hepatoma.
Xiao WH; Sanren GW; Zhu JH; Li QW; Kang HR; Wang RL; Song LP; Ye M
World J Gastroenterol; 2010 May; 16(19):2371-7. PubMed ID: 20480522
[TBL] [Abstract][Full Text] [Related]
5. DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas.
Nie Y; Yang G; Song Y; Zhao X; So C; Liao J; Wang LD; Yang CS
Carcinogenesis; 2001 Oct; 22(10):1615-23. PubMed ID: 11577000
[TBL] [Abstract][Full Text] [Related]
6. Modulation of HLA-G expression.
Polakova K; Bandzuchova E; Tirpakova J; Kuba D; Russ G
Neoplasma; 2007; 54(6):455-62. PubMed ID: 17949227
[TBL] [Abstract][Full Text] [Related]
7. Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2'-deoxycytidine.
Yan WH; Lin AF; Chang CC; Ferrone S
Cell Res; 2005 Jul; 15(7):523-31. PubMed ID: 16045815
[TBL] [Abstract][Full Text] [Related]
8. Expression of HLA-G in patients with B-cell chronic lymphocytic leukemia (B-CLL).
Giannopoulos K; Dmoszyńska A; Bojarska-Junak A; Schmitt M; Roliński J
Folia Histochem Cytobiol; 2008; 46(4):457-60. PubMed ID: 19141398
[TBL] [Abstract][Full Text] [Related]
9. Decitabine induces very early in vivo DNA methylation changes in blasts from patients with acute myeloid leukemia.
Claus R; Pfeifer D; Almstedt M; Zucknick M; Hackanson B; Plass C; Lübbert M
Leuk Res; 2013 Feb; 37(2):190-6. PubMed ID: 23158571
[TBL] [Abstract][Full Text] [Related]
10. HLA-G gene repression is reversed by demethylation.
Moreau P; Mouillot G; Rousseau P; Marcou C; Dausset J; Carosella ED
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1191-6. PubMed ID: 12552087
[TBL] [Abstract][Full Text] [Related]
11. [Effects of 5-aza-2'-deoxycytidine on the amount of exosomes and secreted immuno-associated proteins by hepatoma cells].
Sanrengaowa ; Wu Y; Xiao WH
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):495-9. PubMed ID: 19950695
[TBL] [Abstract][Full Text] [Related]
12. The DNA demethylating agent 5-aza-2'-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells.
Almstedt M; Blagitko-Dorfs N; Duque-Afonso J; Karbach J; Pfeifer D; Jäger E; Lübbert M
Leuk Res; 2010 Jul; 34(7):899-905. PubMed ID: 20381863
[TBL] [Abstract][Full Text] [Related]
13. Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia.
Fabiani E; Leone G; Giachelia M; D'alo' F; Greco M; Criscuolo M; Guidi F; Rutella S; Hohaus S; Voso MT
Leuk Lymphoma; 2010 Dec; 51(12):2275-84. PubMed ID: 21077739
[TBL] [Abstract][Full Text] [Related]
14. Treatment of chronic lymphocytic leukemia with a hypomethylating agent induces expression of NXF2, an immunogenic cancer testis antigen.
Dubovsky JA; McNeel DG; Powers JJ; Gordon J; Sotomayor EM; Pinilla-Ibarz JA
Clin Cancer Res; 2009 May; 15(10):3406-15. PubMed ID: 19401350
[TBL] [Abstract][Full Text] [Related]
15. The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells.
Flotho C; Claus R; Batz C; Schneider M; Sandrock I; Ihde S; Plass C; Niemeyer CM; Lübbert M
Leukemia; 2009 Jun; 23(6):1019-28. PubMed ID: 19194470
[TBL] [Abstract][Full Text] [Related]
16. The cancer‑testis antigen NXF2 is activated by the hypomethylating agent decitabine in acute leukemia cells in vitro and in vivo.
Zhou J; Li Y; Yao Y; Wang L; Gao L; Gao X; Luo X; Li J; Jiang M; Zhou M; Wang L; Yu L
Mol Med Rep; 2013 Nov; 8(5):1549-55. PubMed ID: 24002123
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic repolarization of T lymphocytes from chronic lymphocytic leukemia patients using 5-aza-2'-deoxycytidine.
Dubovsky JA; Powers JJ; Gao Y; Mariusso LF; Sotomayor EM; Pinilla-Ibarz JA
Leuk Res; 2011 Sep; 35(9):1193-9. PubMed ID: 21377729
[TBL] [Abstract][Full Text] [Related]
18. [The study of 5-Aza-2'-deoxycytidine on transcription regulation of p16/CDKN2 gene demethylation in RKO human colorectal cell line].
Fang XM; Sun LF; Peng JP; Dong Q; Zheng S
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2077-82. PubMed ID: 14703421
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous inhibition of DNA methyltransferase and histone deacetylase induces p53-independent apoptosis via down-regulation of Mcl-1 in acute myelogenous leukemia cells.
Nishioka C; Ikezoe T; Yang J; Udaka K; Yokoyama A
Leuk Res; 2011 Jul; 35(7):932-9. PubMed ID: 21550660
[TBL] [Abstract][Full Text] [Related]
20. Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition.
Raneros AB; Minguela A; Rodriguez RM; Colado E; Bernal T; Anguita E; Mogorron AV; Gil AC; Vidal-Castiñeira JR; Márquez-Kisinousky L; Bulnes PD; Marin AM; Garay MCG; Suarez-Alvarez B; Lopez-Larrea C
Oncotarget; 2017 May; 8(19):31959-31976. PubMed ID: 28404876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]